Abstract
ObjectiveThe Antiplatelet versus R-tPA for Acute Mild Ischaemic Stroke trial has demonstrated the non-inferiority of dual antiplatelet therapy (DAPT) to alteplase in minor non-disabling stroke. This prespecified secondary analysis aimed...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have